Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Glaukos Corp (GKOS)

Glaukos Corp (GKOS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Glaukos Corp ONE GLAUKOS WAY ALISO VIEJO CA 92656 USA

P: 949-367-9600 F: 949-367-9984

Description:

Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally.

Key Statistics

Overview:

Market Capitalization, $K 2,303,100
Enterprise Value, $K 1,889,050
Shares Outstanding, K 47,703
Annual Sales, $ 294,010 K
Annual Net Income, $ -49,590 K
Last Quarter Sales, $ 71,270 K
Last Quarter Net Income, $ -27,580 K
60-Month Beta 1.23
% of Insider Shareholders 8.10%
% of Institutional Shareholders 92.17%
Float, K 43,839
% Float 91.90%
Short Volume Ratio 0.42

Growth:

1-Year Return -4.92%
3-Year Return -24.03%
5-Year Return 66.14%
5-Year Revenue Growth 157.00%
5-Year Earnings Growth -791.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.45 on 11/02/22
Next Earnings Date 02/28/23
Earnings Per Share ttm -1.97
EPS Growth vs. Prev Qtr 45.78%
EPS Growth vs. Prev Year -136.84%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GKOS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.16%
Return-on-Assets % -8.96%
Profit Margin % -16.87
Net Margin % N/A
Debt/Equity 0.64
Price/Sales 8.01
Price/Cash Flow N/A
Price/Book 4.15
Book Value/Share 11.59
Interest Coverage -2.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar